These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 12042891

  • 1. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.
    Sorof JM, Cargo P, Graepel J, Humphrey D, King E, Rolf C, Cunningham RJ.
    Pediatr Nephrol; 2002 May; 17(5):345-50. PubMed ID: 12042891
    [Abstract] [Full Text] [Related]

  • 2. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V, Hainer JW, Sugg J, Munzer D, ATTACH Study Group.
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [Abstract] [Full Text] [Related]

  • 3. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 4. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.
    Frishman WH, Bryzinski BS, Coulson LR, DeQuattro VL, Vlachakis ND, Mroczek WJ, Dukart G, Goldberg JD, Alemayehu D, Koury K.
    Arch Intern Med; 1994 Jul 11; 154(13):1461-8. PubMed ID: 8018001
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 11; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 6. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
    Punzi HA, Punzi CF.
    J Hum Hypertens; 2004 Sep 11; 18(9):655-61. PubMed ID: 15042114
    [Abstract] [Full Text] [Related]

  • 7. Treatment of hypertension in the very old.
    Otterstad JE, Ruilope LM.
    Int J Clin Pract Suppl; 2000 Nov 11; (114):10-9. PubMed ID: 11221289
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug 11; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 9. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW, Rubino J, Zhang H, Shahinfar S, Soffer BA, Lyle PA, Littlejohn TW, Feig PU.
    Clin Ther; 2006 Oct 11; 28(10):1639-48. PubMed ID: 17157119
    [Abstract] [Full Text] [Related]

  • 10. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov 11; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul 11; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 12. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH, Hainer JW, Sugg J, M-FACT Study Group.
    Am J Hypertens; 2006 Apr 11; 19(4):388-95. PubMed ID: 16580575
    [Abstract] [Full Text] [Related]

  • 13. Low-dose bisoprolol/hydrochlorothiazide: an option in first-line, antihypertensive treatment.
    Zachariah PK, Messerli FH, Mroczek W.
    Clin Ther; 1993 Apr 11; 15(5):779-87. PubMed ID: 8269444
    [Abstract] [Full Text] [Related]

  • 14. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
    Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Smith B, Weissbach N, Maboudian M, Botha J, van Ingen H.
    Circulation; 2009 Jan 27; 119(3):417-25. PubMed ID: 19139391
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar 27; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

  • 16. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 27; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 17. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A.
    Am J Hypertens; 2007 Jan 27; 20(1):11-20. PubMed ID: 17198906
    [Abstract] [Full Text] [Related]

  • 18. Losartan with hydrochlorothiazide in the treatment of hypertension.
    Schoenberger JA, Losartan Research Group.
    J Hypertens Suppl; 1995 Jul 27; 13(1):S43-7. PubMed ID: 18800455
    [Abstract] [Full Text] [Related]

  • 19. Comparison of benazepril-amlodipine and captopril-thiazide combinations in the management of mild-to-moderate hypertension.
    Malacco E, Piazza S, Carretta R, Di Somma S, Mugellini A, Bertocchi F, Palatini P, Italian Blood Pressure Study Group.
    Int J Clin Pharmacol Ther; 2002 Jun 27; 40(6):263-9. PubMed ID: 12078940
    [Abstract] [Full Text] [Related]

  • 20. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 27; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.